Literature DB >> 22943384

Enhanced random skin flap survival by sustained delivery of fibroblast growth factor 2 in rats.

Hyoung Joon Park1, Seahyoung Lee, Kyo Hwa Kang, Chan Yeong Heo, Ji Hoon Kim, Hee Seok Yang, Byung-Soo Kim.   

Abstract

BACKGROUND: Skin flap survival is a major challenge in reconstructive plastic surgery. Here, we examined the effect of sustained delivery of fibroblast growth factor 2 (FGF2) using heparin-conjugated fibrin (HCF) on skin flap survival in rats.
METHODS: Rats with a skin flap received either phosphate-buffered saline/FGF2 or HCF/FGF2 in the recipient bed. For the no-treatment group, a random skin flap was sutured on the back without any treatment. Seven days after surgery, angiogenesis in the skin flap was evaluated by using Visitrak system and conventional healing quality scoring method. The efficacy of HCF/FGF2 in skin flap survival was evaluated by comparing the results from different groups.
RESULTS: The necrotic area of the skin flap significantly decreased in the HCF/FGF2 group as compared with the other groups.
CONCLUSION: The sustained delivery of FGF2 using HCF has a therapeutic potential to improve skin flap survival.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943384     DOI: 10.1111/j.1445-2197.2012.06194.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  2 in total

Review 1.  Therapeutic strategies for enhancing angiogenesis in wound healing.

Authors:  Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker
Journal:  Adv Drug Deliv Rev       Date:  2018-09-26       Impact factor: 15.470

2.  Combined plasma rich in growth factors and adipose-derived mesenchymal stem cells promotes the cutaneous wound healing in rabbits.

Authors:  Deborah Chicharro; Jose M Carrillo; Mónica Rubio; Ramón Cugat; Belén Cuervo; Silvia Guil; Jerónimo Forteza; Victoria Moreno; Jose M Vilar; Joaquín Sopena
Journal:  BMC Vet Res       Date:  2018-09-21       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.